[29 cases of malaria introduced into New Caledonia from 1992 to 1995].
Although located in a tropical zone of the South Pacific, the island of New Caledonia is malaria-free. This retrospective study of imported malaria was conducted jointly by the Pasteur Institute of New Caledonia and the Gaston Bourret Territorial Hospital between January 1, 1992 and December 31, 1995. A total of 29 patients were hospitalized for malaria. Most contracted the disease in Vanuatu. Plasmodium vivax was involved more often than Plasmodium falciparum (22 vs. 11). No case was severe, complicated, or fatal. In most cases treatment consisted of quinine followed by mefloquine. The median duration of hospitalization was 5.7 days. Since the annual incidence of imported malaria is significantly higher in New Caledonia than in France, the authors propose that a Travelers Information Center should be set up in New Caledonia to improve prophylaxis against malaria.
Monchy
D
D
Laboratoire d'Hématologie, Institut Pasteur de Nouvelle-Calédonie.
Descamps
I
I
Barguil
Y
Y
Levenes
H
H
Genelle
B
B
D000293:Adolescent; D000328:Adult; D000962:Antimalarials / Q000627:therapeutic use; D005260:Female; D005602:France / Q000453:epidemiology; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D007902:Length of Stay / Q000706:statistics & numerical data; D008288:Malaria / Q000453:epidemiology* / Q000517:prevention & control; D016778:Malaria, Falciparum / Q000453:epidemiology / Q000517:prevention & control; D016780:Malaria, Vivax / Q000453:epidemiology / Q000517:prevention & control; D008297:Male; D015767:Mefloquine / Q000627:therapeutic use; D009510:New Caledonia / Q000453:epidemiology; D011803:Quinine / Q000627:therapeutic use; D012189:Retrospective Studies; D014195:Travel
D000962:Antimalarials; D011803:Quinine; D015767:Mefloquine